Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review

We previously designed and synthesized dehydroxyepoxyquinomicin (DHMEQ) as an inhibitor of NF-κB based on the structure of microbial secondary metabolite epoxyquinomicin C. DHMEQ showed anti-inflammatory and anticancer activity in various in vivo disease models without toxicity. On the other hand, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yinzhi, Ukaji, Tamami, Koide, Naoki, Umezawa, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877590/
https://www.ncbi.nlm.nih.gov/pubmed/29510517
http://dx.doi.org/10.3390/ijms19030729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877590/
https://www.ncbi.nlm.nih.gov/pubmed/29510517
http://dx.doi.org/10.3390/ijms19030729

Ejemplares similares